PT-141 — Rainbow Peptide
🧪 HPLC Verified
>98% Purity
📄 COA Included
APEX Performance & Metabolic

PT-141

$48.52

PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist approved by the FDA as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women. It acts centrally via MC3R/MC4R, distinct from PDE5 inhibitor mechanisms.

Format Lyophilized Vial
Dosage 10mg
Purity >98%
Sub-Line APEX

In Stock — Overnight and 2–3 day delivery available

Product Information

PT-141 | Bremelanotide Melanocortin Agonist — Research Grade

PT-141 (Bremelanotide) is a cyclic heptapeptide analogue of alpha-MSH and the first melanocortin-based compound to receive FDA approval for sexual dysfunction. Approved as Vyleesi in June 2019 for HSDD in premenopausal women, it provides a uniquely strong clinical evidence base for research use.

Mechanism of Action

  • MC3R/MC4R agonism — activates hypothalamic melanocortin receptors involved in sexual arousal circuitry
  • Central (not peripheral) action — works upstream of the vascular events targeted by PDE5 inhibitors, offering a complementary research tool
  • No cardiovascular dependency — does not require nitric oxide/cGMP pathway intact (relevant in diabetic neuropathy models)

Research Areas

PT-141 is studied in male and female sexual dysfunction, melanocortin neurocircuitry, obesity (MC4R), and inflammatory pain. Phase III RECONNECT trial (n=1,267) demonstrated significant HSDD improvement vs placebo.

For Research Use Only. Rainbow Peptide supplies PT-141 exclusively for in vitro and laboratory research purposes. Not for human or veterinary use.

Frequently Asked Questions

What is PT-141?
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist approved by the FDA as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women. It acts centrally via MC3R/MC4R, distinct from PDE5 inhibitor mechanisms.
Is PT-141 for sale at Rainbow Peptide?
Yes. PT-141 is available for purchase with Certificate of Analysis confirming >98% HPLC purity. Every order Overnight and 2–3 day delivery available. For Research Use Only.
What purity is your PT-141?
Rainbow Peptide's PT-141 is >98% pure, HPLC verified by an accredited third-party laboratory. A COA is included with every order.
Is PT-141 safe for human use?
No. PT-141 is strictly For Research Use Only (RUO). It is not intended for human consumption and is not intended to diagnose, treat, cure, or prevent any disease.
How quickly does PT-141 ship?
Overnight and 2–3 day delivery available. Ships in temperature-controlled packaging.

Third-Party Verified

Every Order Ships with a Certificate of Analysis

We don't just claim purity — we prove it. Every batch of PT-141 is independently tested by an accredited third-party laboratory before it reaches you. Your COA is linked to your specific lot number.

  • HPLC purity analysis — minimum threshold >98%
  • Mass spectrometry — molecular weight confirmation
  • Lot number traceable to your order
  • Endotoxin limits verified — safe for cell-based assays
RAINBOW PEPTIDE LABS CERTIFICATE OF ANALYSIS
Product PT-141
Lot # RP-00027-A
HPLC Purity >98.0% >98.5% PASS
Mass Spec (MW) Confirmed Confirmed PASS
Endotoxin <1 EU/mg <0.5 EU/mg PASS
Visual Inspection White powder White powder PASS

What Researchers Say

Verified purchases from active research labs and scientists

5.00
2 verified reviews
CW
Dr. C. Walsh Metabolic Assay
★★★★★

Retatrutide purity was outstanding

Running metabolic assays with Retatrutide. Lot had >99% purity by reverse-phase HPLC — above spec. Mass spec confirmed molecular weight. Best peptide supplier we've worked with.

DP
D. Pearson GH Secretion Model
★★★★★

Ipamorelin quality confirmed via QC

Internal verification confirmed COA data. Purity was 98.6% HPLC. Peptide behavior in our assay was consistent with published data. Will order again for next study phase.

BS
B. Stanton Metabolic Rate Study
★★★★

Consistent performance for research

AOD-9604 arrived quickly and in excellent condition. Cold pack preserved temperature. COA was thorough. Results in metabolic assays consistent with expected parameters.